AXSM - Axsome Therapeutics Inc
IEX Last Trade
88.73
-0.380 -0.428%
Share volume: 311,826
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$89.11
-0.38
-0.43%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-07 | 2023-02-28 | 2023-05-09 | 2023-08-07 | 2023-11-06 | 2024-02-23 | 2024-05-06 | |
| Total revenue | 8.820 M | 16.846 M | 24.372 M | 94.576 M | 46.700 M | 57.794 M | 71.530 M | 74.999 M | |
| Cost of revenue | 982.836 K | 1.924 M | 2.291 M | 7.556 M | 4.599 M | 6.532 M | 7.378 M | 6.297 M | |
| Gross profit | 7.837 M | 14.922 M | 22.081 M | 87.020 M | 42.101 M | 51.262 M | 64.152 M | 68.702 M | |
| 90.41% | 47.97% | 294.10% | -51.62% | 21.76% | 25.15% | 7.09% | |||
| Operating expenses | 46.952 M | 55.769 M | 76.190 M | 91.984 M | 99.516 M | 111.955 M | 117.612 M | 135.800 M | |
| Selling general and admin | 31.160 M | 40.892 M | 61.497 M | 74.191 M | 78.935 M | 83.188 M | 86.809 M | 98.970 M | |
| Research and development | 15.792 M | 14.877 M | 14.693 M | 17.793 M | 20.581 M | 28.767 M | 30.803 M | 36.830 M | |
| Total expenses | 48.861 M | 59.300 M | 80.088 M | 101.112 M | 105.704 M | 120.094 M | 126.597 M | 143.686 M | |
| 21.37% | 35.06% | 26.25% | 4.54% | 13.61% | 5.41% | 13.50% | |||
| Operating income | -40.041 M | -42.454 M | -55.717 M | -6.536 M | -59.004 M | -62.300 M | -55.067 M | -68.687 M | |
| Ebit | -40.041 M | -42.454 M | -55.717 M | -6.536 M | -59.004 M | -62.300 M | -55.067 M | -68.687 M | |
| Pretax income | -41.439 M | -44.823 M | -61.240 M | -8.638 M | -67.787 M | -62.877 M | -98.976 M | -68.357 M | |
| 8.17% | 36.62% | -85.89% | 684.75% | -7.24% | 57.41% | -30.94% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 2.580 M | -617.000 K | -678.000 K | -325.000 K | 0.000 | |
| Net income basic | -41.439 M | -44.823 M | -61.240 M | -11.218 M | -67.170 M | -62.199 M | -98.651 M | -68.357 M | |
| -8.17% | -36.62% | 81.68% | -498.77% | 7.40% | -58.61% | 30.71% | |||
| Net income | -41.439 M | -44.823 M | -61.240 M | -11.218 M | -67.170 M | -62.199 M | -98.651 M | -68.357 M | |
| -8.17% | -36.62% | 81.68% | -498.77% | 7.40% | -58.61% | 30.71% |